Teleflex (NYSE:TFX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Teleflex (NYSE:TFX) in the last three months. The table below provides a snapshot of their ...

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected ...

As of Thursday, February 26, Teleflex Incorporated’s TFX share price has surged by 7.09%, which has investors questioning if this is right time to sell.

Teleflex’s second quarter results were marked by positive market reaction, driven largely by operational outperformance in its Interventional segment and effective margin management. Management ...

Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow before market hours. Here’s what to expect.

Medical technology company Teleflex (NYSE:TFX) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 28.5% year on year to $569 million. Its non-GAAP profit of $1.93 per share was ...

Teleflex ( (TFX)) has issued an update. Teleflex Incorporated reported a 2.4% increase in GAAP revenue for Q3 2024, reaching $764.4 million, with strong contributions from Interventional and Vascular ...

Apollon Wealth Management LLC boosted its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 10.8% in the fourth quarter, according to the company in its most recent disclosure with the ...

GAMMA Investing LLC lessened its position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 21.4% during the first quarter, according to its most recent filing with the Securities & ...